Evidence map›Paper›PMID 40346045›Full record

ArticleNature communications2025

Redox-driven photoselective self-assembly.

Dario Alessi, Luca Morgan, Elisa Pelorosso, Claudia Graiff, Piermaria Pinter, Alessandro Aliprandi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Reinventing Chemiluminescence through Redox-Driven Self-Assembly.Journal of the American Chemical Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dario AlessiDipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131, Padova, Italy.
Luca MorganDipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131, Padova, Italy.
Elisa PelorossoDipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131, Padova, Italy.
Claudia GraiffDepartment of Chemistry, Life Sciences and Environmental Sustainability, Università degli Studi di Parma, Parco Area delle Scienze 17/A, 43124, Parma, Italy.ORCID http://orcid.org/0000-0002-9908-6961
Piermaria PinterNovaled GmbH, Elisabeth-Boer-Straße 9, 01099, Dresden, Germany.
Alessandro AliprandiDipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131, Padova, Italy. alessandro.aliprandi@unipd.it.ORCID http://orcid.org/0000-0002-2647-9967

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 949087Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) 2022ETBCER
6 · The paper itself

Abstract

Self-assembly via non-covalent interactions is key to constructing complex architectures with advanced functionalities. A noncovalent synthetic chemistry approach, akin to organic chemistry, allows stepwise construction with enhanced control. Here, we explore this by coupling Pt(II) complex self-assembly with a redox reaction. Oxidation to Pt(IV) creates a non-emissive monomer that, upon reduction to Pt(II), forms luminescent gels with unique kinetic and thermodynamic pathways. UV irradiation induces Pt(IV) reduction, generating supramolecular fibers with Pt∙∙∙Pt interactions, enhancing photophysical properties and enabling visible light absorption up to 550 nm. This allows photoselective growth, where fibers convert surrounding Pt(IV) to Pt(II), promoting growth over nucleation, as observed via real-time fluorescence microscopy.

Identifiers

PMID40346045
PMCPMC12064647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.